Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946
Sort by:

Toll Like Receptor 5 (Toll-Interleukin 1 Receptor Like Protein 3 or TLR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Toll Like Receptor 5 (Toll-Interleukin 1 Receptor Like Protein 3 or TLR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Recep...

May 2022 39 pages

Toll Like Receptor 9 (CD289 or TLR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Toll Like Receptor 9 (CD289 or TLR9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Receptor 9 (CD289 or TLR9) Drugs in Develo...

May 2022 72 pages

Toll Like Receptor Family (TLR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Toll Like Receptor Family (TLR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Toll Like Receptor Family (TLR) Drugs in Development by T...

May 2022 227 pages

Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tonic-Clonic (Grand Mal) Seizure Drugs in Development by Stages, Target, MoA, R...

May 2022 37 pages

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY TRAF2 and NCK Interacting...

May 2022 35 pages

Trans Activator Of Transcription (Tat) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Trans Activator Of Transcription (Tat) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Trans Activator Of Transcription (Tat) Drugs in De...

May 2022 36 pages

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transferrin Receptor Protein 1...

May 2022 40 pages

Transferrin Receptor (TFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transferrin Receptor (TFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transferrin Receptor (TFR) Drugs in Development by Therapy Are...

May 2022 51 pages

Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Transformed Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 37 pages

Transforming Growth Factor Beta 3 (TGFB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transforming Growth Factor Beta 3 (TGFB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor Beta 3 (TGFB3) Drugs...

May 2022 37 pages

Transforming Growth Factor Beta (TGFb) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Transforming Growth Factor Beta (TGFb) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor Beta (TGFb) Drugs in De...

May 2022 141 pages

Transforming Growth Factor (TGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Transforming Growth Factor (TGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transforming Growth Factor (TGF) Drugs in Development by...

May 2022 184 pages

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Transitional Cell Carcinoma (Urothelial Cell Carcinoma)...

May 2022 171 pages

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 36 pages

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Transmembra...

May 2022 46 pages

Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trauma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 53 pages

Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traumatic Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 37 pages

Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Travelers Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Traveler's Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key P...

May 2022 41 pages

Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 81 pages

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 37 pages

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 37 pages

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tropomyosin Receptor Kinase (TRK or EC 2...

May 2022 107 pages

Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Trypanosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 133 pages

Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Tuberous Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 46 pages

Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 247 pages

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 177 pages

Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Turner Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 35 pages

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMAR...

May 2022 86 pages

Tyrosine Protein Kinase Lyn (Lck-Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Tyrosine Protein Kinase Lyn (Lck-Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) Drugs in Development b...

May 2022 39 pages

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tyrosine Protei...

May 2022 68 pages

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Tyrosyl DNA Phosphodiesterase 1 (TDP1...

May 2022 35 pages

Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 57 pages

Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Upper Limb Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 41 pages

Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urea Cycle Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 70 pages

Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Uremic (Renal) Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 40 pages

Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 64 pages

Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urinary Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 132 pages

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Drugs in Devel...

May 2022 36 pages

Usherin (Usher Syndrome Type 2A Protein or USH2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Usherin (Usher Syndrome Type 2A Protein or USH2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Usherin (Usher Syndrome Type 2A Protein...

May 2022 39 pages

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Utrophin (Dystrophin Related Prot...

May 2022 35 pages

Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Varicella Zoster (HHV-3) Infections Drugs in Development by Stages, Target,...

May 2022 74 pages

Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Dementias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 45 pages

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular End...

May 2022 164 pages

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 35 pages

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Vascu...

May 2022 35 pages

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Endothelial G...

May 2022 190 pages

Vascular Endothelial Growth Factor (VEGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Vascular Endothelial Growth Factor (VEGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Endothelial Growth Factor (VEGF) Drugs...

May 2022 286 pages

Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vascular Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Vasomotor Symptoms of Menopause (Hot Flashes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Vasomotor Symptoms of Menopause (Hot Flashes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Vasomotor Symptoms of Menopause (Hot Flashes) Drugs in Development...

May 2022 42 pages

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular-Hepatic Type Arginine Vasopressin Receptor or AVPR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular-Hepatic Type Arginine Vasopressin Receptor or AVPR1A) Drugs in Development by Therapy Areas and Indications, Stages,...

May 2022 44 pages

Filters

Search

Categories

209
1,199
32
238
214
187
155
140
64,297
1,312
1,311
2,468
184

Publishers

179
1
1,431
239
366
389
103
148
348
3
202
3
6
1,620
487
80
123
208
112
25
1,049
378
23
40
68
510
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,709
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
384
8
3
18
58
907
6
89
12
24
15
1,285
227
128
386
3
74
10
119
227
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
797
497
2
2
2
118
197
102
54
23
708
26
135
530
177
646
66,872

Price

—

Date

—

Pages

—

Offers

1
280
1
1